Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study of miltefosine and sodium stibogluconate for Old World cutaneous leishmaniasis in Kandahar
TCTR20180710007Phase 2Completed
- Sponsor
- University of Oxford
- Start
- Dec 2019
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of miltefosine, sodium stibogluconate in cutaneous leishmaniasis (CL), sponsored by University of Oxford. Started Dec 2019; status: completed.
02
Drugs
miltefosinesodium stibogluconate
03
Conditions
cutaneous leishmaniasis (CL)
Beyond the preview
Go deeper on TCTR20180710007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20180710007.